See:
Pages
- Home
- About Dr. Tim Sandle
- Technical articles (free)
- Publications by Tim Sandle
- Microbiology books by Tim Sandle
- Other books by Tim Sandle
- Pharma Microbiology MSc
- Microbiology Sites
- Presentations by Tim Sandle
- Advertise here
- Write for us
- About this site
- Useful Links
- Science and microbiology videos
- Privacy Policy
Monday 29 February 2016
Shellfish toxins
Sunday 28 February 2016
Protein purification workflow
Identifying
and establishing an efficient protein recovery process can be a time-consuming endeavour.
In addition, a case study compares the traditional sequential chromatography to
a multidimensional workflow, demonstrating that both methods yield proteins of
equivalent purity.
To
assist with this, Pharmaceutical Process has issues a new e-book. The e–book shares
best practices for downstream purification, and shows how continuous
purification methods can offer increased productivity and greater process
reliability and reproducibility in the laboratory and when scaling protein
purification processes for the production of commercial quantities.
In
addition, a case study compares the traditional sequential chromatography to a
multidimensional workflow, demonstrating that both methods yield proteins of
equivalent purity.
Posted by Dr. Tim Sandle
Saturday 27 February 2016
Microbe Menaces Emerging Infectious Diseases
Infection
Control Today have a free digital issue on the subject “Microbe Menaces
Emerging Infectious Diseases, Hospital Pathogens Remain an Ongoing Challenge”.
Posted by Dr. Tim Sandle
Friday 26 February 2016
Lessons Learned in the Cleanroom
Cleanroom
components: Install anti-contamination flooring to minimize particulate
carry-over, both foot-borne and from cart wheels. Find a qualified third party
expert to annually certify the acceptable performance of the air handling
systems inside the controlled areas (HEPA filters, BSC, LFH, isolators).
Integrate automation/robotics when feasible to limit interventions by
personnel.
In
relation to this by Deborah Hoffer has written an article for Controlled
Environments magazine. The piece can be
accessed here.
Posted by Dr. Tim Sandle
Thursday 25 February 2016
Sporicides – As Part Of Your Transfer Process in Practice
Do you monitor, run or work in an aspectic facility? If yes – you should be attending this event!
Posted by Dr. Tim Sandle
Please see below (or contact Pharmig):
Posted by Dr. Tim Sandle
Environmental Monitoring Program: Hot topics in Microbiology & Best Practices
The
manufacture of sterile pharmaceutical product requires specific care Regarding
environment, premises and practice of the personnel. Regulations in place to be
used by the Pharmaceutical Industry give requirements on the environmental
monitoring program. With the publication of FDA Warning Letters and 483 That
form shows environmental monitoring procedure and practice of the staff belong
to top 10 of the gaps found During inspections.
Benedict
RAMOND has written an interesting article for the magazine La Vague. The article can
be found here.
Here
is an extract:
Posted by Dr. Tim Sandle
Bromate and water
The determination of the bromate content of water is a challenge that can be met either by using an elaborate ion chromatography system or a photometric method. Both approaches demand careful handling and a critical appraisal of the result that is yielded. If the necessary working steps are carefully followed, photometry constitutes a true alternative to chromatography for those laboratories that do not possess ion chromatography systems.
Posted by Dr. Tim Sandle
Wednesday 24 February 2016
Best Practices in Environmental Monitoring:
A new Pharmig one day course - 'Best Practices in Environmental Monitoring'.
For details see:
Posted by Dr. Tim Sandle
For details see:
Posted by Dr. Tim Sandle
Has A New Form Of Microbial Life Been Discovered?
The human intestines are home to trillions of microorganisms (many bacteria, some fungi, and by-products – collectively known as the microbiome). Several strands of research are showing how the numbers and types of certain bacteria are important for the regulation of immune function and how disruption can lead to autoimmune diseases.
New research suggests we may need to re-consider how we track and categorize the microorganisms within this ecosystem. Scientists at the Pierre and Marie Curie University in Paris, France are looking at how to redefine the classification of bacteria found within the colon. This is through examining 86 gene families using next-generation sequencing methods.
The findings suggest the current three categories for microbial life – bacteria, archaea, and eukaryotes (which includes fungi and single-celled parasitic animals) – could be insufficient. In short, a case could be made for a fourth type of microbial life. These microbes are lurking in what is termed “microbial dark matter.”
According to New Scientist magazine, the research group found 230,000 DNA sequences that are related to known sequences in those 86 gene families. This analysis found “an additional 80,000 stretches of microbial DNA that belonged in the 86 gene families.”
There is a lot of work to do, and evidence gathering to complete, before a firm case is made for a fourth domain and before this becomes universally accepted in the microbiology world. This includes isolating and culturing the organisms. Finding a means to do this, given most microbes are unculturable, will be difficult.
The researchers have put forward the notion in the journal Biology Direct. The research paper is headed “Highly divergent ancient gene families in metagenomic samples are compatible with additional divisions of life.”Posted by Dr. Tim Sandle
Tuesday 23 February 2016
Microbiomes and stress
If you are feeling stressed, your microbiome – the communities of microbes living in and on you – may be suffering too. A team at the University of Guelph, Canada, studied the link between stress and microbiomes in wild red squirrels, and found that individuals with low stress hormone levels had a more diverse microbiome, while increased stress caused a spike in potentially harmful bacteria, but less bacterial diversity.
See:
Monday 22 February 2016
ISO 14644 Part 13 - public comment
Part 13 of the revised international cleanroom standard is available for public comment. The details are:
‘Surface’ refers to the interface between two phases. For the purpose of this document, the surface is a solid.
“Clean surface” is where one or more of the contamination categories (particles, chemical) are under control
due to cleaning / decontamination. The degree of cleanliness is specified in the corresponding surface
cleanliness classifications (ISO 14644-9:2012 Surface cleanliness by particle concentration SCP; ISO 14644-
10:2013 Surface cleanliness by chemical concentration SCC). Different cleaning methods are necessary
depending on the degree of cleanliness (cleanliness class) required. This standard gives guidance on the
selection of cleaning methods to achieve specified cleanliness levels. For the selection procedure, the aspects
of surface description, cleanliness specifications, types of contamination, cleaning techniques, material
compatibility, and assessment methodology are taken into consideration. Most of the methods are suitable for
removal of more than one contamination category at the same time therefore a common standard for the
selection of a cleaning method for both particles as well as chemical contamination is needed.
Guidance
is provided on the assessment of cleaning methods for achieving the required
surface cleanliness levels specified in ISO 14644-9: Classification of surface
cleanliness by particle concentration and ISO 14644-10: Classification of
surface cleanliness by chemical concentration. Different cleaning methods may
be necessary depending on the degree of cleanliness required. The selection
procedure considers aspects such as surface description, cleanliness
specifications, types of contamination, cleaning techniques, and material
compatibility. Guidance is provided on assessing cleaning efficacy.
The reference is:
Sunday 21 February 2016
Striving for the highest Grade
As a prototype for the future, is it possible to consider an energy
efficient filter system that cost-effectively maintains airflow towards a
reduced rate of change? Michael Rodd, Chief Sales Officer at M+W Products (www.products.mwgroup.net) looks at elements of life sciences in the
clean room and envisages how future practice can radically change the concept
of clean room procedures.
It is common to expect the output
of a clean room operation to end as a microprocessor in your phone, laptop or
car, but in fact, the first measured effort to control an environment was used
for medicinal purposes on a table in a hospital. British surgeon Joseph Lister
in 1867, at a time when multiple surgeries were performed using the same
contaminated equipment, sterilised his hand using carbolic acid and
experimented implementing this technique on wounds and needles to discover the
elimination of bacteria.
Although much has changed since,
and both our efforts and realisations of scientific procedures have adapted,
the dedication of modern life sciences was reinvigorated as
a fairly new discipline of the clean room subdivision over the last century. This
process encapsulates everything utilised by the way of clean room technologies
in the production of medical substances, pharmaceuticals and biological
compounds.
As the history of the pharma
world displays, our requirement for a clean room stems from the need for
contamination control. Whether that’s using gloves during primitive operations
or alcohol as an antiseptic to sterilise needles or creating paint and lacquer
work out in uncontaminated air near the Pacific Ocean, our need to benefit from
such processes has been fuelled by the requirement to control and clean our
imminent environment.
This demonstrates something else
too – that the clean room has developed from a permutation of science and
engineering – assessing scientific processes that have worked and engineering
them to deliver better results. This multidisciplinary approach has been
encased by technological practices available at certain periods of time.
Fundamental to the field of life
sciences and pharmaceutical micro biotechnology is contamination control. First
and foremost, the apparatus used for pharmaceuticals in clean room laboratories
should be dedicated and separated from other areas. Nailed down, this involves
the classification between protecting the working environment and protecting
the operator from any potential contamination. This is because humans remain
the biggest cause of contamination; that may never change. To put this into
perspective, the outer layer of human skin can host up to 1 million
microorganisms per square cm, and equally, human saliva up to 1 billion per
square ml.
The frenzy of microbes is
difficult to keep on top of at every stage of the process. Basic negligence can
cause the microorganisms from our clothes, mobile phones or bare skin to
contaminate working stations. For instance, hands, whether gloved or un-gloved,
are one of the main sources of spreading infection or transferring microbial
contamination. Thus, an important part of good contamination control within a
cleanroom requires the use of cleaning and disinfection agents. It goes without
saying that just as personnel may be the biggest contaminants, they are also
critical to the maintenance of asepsis in a controlled environment.
Therefore diligence and training in clean room technology is essential
throughout the entire process.
The improper analysis of
microbiological inspections may cause inadvertent contamination. Therefore, thorough
aseptic processing like product or microbial bioburden to calculate viable
organisms is needed to prevent any sort of contamination during the process
stream. In some cases, even measuring total particulate count within a vessel
does not cater for the continuous generation of organisms by individuals;
therefore it does not always quantitate all contaminants and provide the whole
picture of microbiological content. Microorganisms will associate with physical
particulates and therefore it is necessary to include monitoring techniques
that satisfy both the classification and regulatory requirements by
differentiating the microbiological components of an operation. Stringent
optimisation of tests will give assurance that bioburden of the environment is
apt for clean laboratory practices.
In its simplest form, a product
being operated within a clean room during a process line includes an enclosed
vessel or large container that is sealed from external air temperature.
Throughout this process, it is the aim of every operative to maintain
conditions to a level where they can be declared sterile or aseptic.
A clean room is classified based
on the cleanliness of its air so as far as clean rooms go, anyone wants to keep
the environment as clean as possible. One of the trends we’ve seen across this
spectrum (and it is a large spectrum) is on the lower end quality scale
concerned with areas that are Clean Not
Classified (CNC). These are areas that can be regarded clean within definitive purposes of the word in regards to the
production area, but they are not actually classified
because they work on a process we call Good Manufacturing Practice (GMP) or
Current Good Manufacturing Practice (CGMP).
The ability to manufacture
medical devices with consistent high quality relies on well implemented and
well documented GMP. The GMP code sets out a guideline to achieve sterility
assurance. Any business that delivers clean room technology requires constant
monitoring and up-to-date certification.
The measurement most universally
applied is the Grade A-D standard, whereby a cubic foot sample is taken of the
environment and the number of particles greater than 0.5mm measured within
it. Areas are classified on a graded
system from A onwards, with A being the cleanest.
So the purpose of a low quality CNC is to effectively get as close as possible
to classification. D certified environments accept the inclusion of certain
particles even in dynamic conditions (i.e. when people are operating within
contained vessels) with turbulent airflow, whereas A certified environments
deal with linear laminated airflow that is non-turbulent. Cleanliness is
commonly achieved through the development of effective HEPA (High Efficiency
Particulate Air) filtration and this is considered as clean as necessary for a
GMP Grade A condition.
Let’s complicate things a step
further. Introduced here is the onion concept. Its name is derived from the idea
that as you peel the onion, a processor must past through successive cleaner
areas to reach the centre, non-turbulent, Grade A area. In essence, the onion
concept caters for the disposal of multiple grade conditions within the same
vessel or container.
Furthermore, the application of
disinfectants on specimens reduces the microbial bioburden as we discussed
earlier. Therefore, when collecting environmental monitoring samples, personnel
should begin with Grade A locations and then move on to areas that are away
from technical apparatus but still within the controlled zone.
This grade system is applicable
in cases where processors and products are exposed during transportation, or
operations that are required to be performed outside of sealed compartments.
Grade B is commonly of high purity but does not necessarily involve laminate
air flow. So the trick here lies in maintaining airflow to a certain speed. Essentially,
imagine the onion concept: each time a layer of the onion is peeled, the amount
of particulate or contaminated risk to the product is reduced.
New developments with antimicrobial viruses
Scientists from the National Physical Laboratory (NPL) and
University College London (UCL) have converted a breast milk protein into an
artificial virus that kills bacteria on contact.
The antimicrobial activities of this protein are mainly due to a
tiny fragment, less than a nanometer across, made up of six amino acids. Based
on the metrology of antimicrobial mechanisms, the team predicted that copies of
this fragment gather at the same time, and at the same point, to attack
bacterial cells by targeting and disrupting microbial membranes.
Posted by Dr. Tim Sandle
Tuberculosis Is Coming Back – Here’s Why
A special report by Megan Ray Nichols.
During the last 20 years, overuse of antibiotics has helped to create drug-resistant strains of the bacterium that have turned tuberculosis from a Victorian-era disease that was often romanticized into something that needs to be feared and respected once again.
Concentration in Cases
While the overall number of tuberculosis cases in the U.S. is dropping, a number of population subsets are increasingly affected by the disease.
A number of factors put individuals at risk for contracting TB, including weakened immune systems or medical professionals pass on the infection after treating infected patients. A 2014 report by the CDC revealed some worrisome trends, including the fact that more than 50 percent of TB cases are concentrated in four states: Florida, New York, Texas and Florida.
What do those four states have in common? They are also the main entry points for immigrants, both legal and illegal, who are entering the United States. As of 2013, more than 64 percent of TB cases were diagnosed in foreign-born individuals who had come to the United States.
Since a standard case of TB often costs around $17,000 to treat, many people who don’t have access to health care or insurance often go untreated, spreading the disease to anyone that they may come into contact with. Drug-resistant TB can cost even more, with a full treatment reaching $134,000. Extreme drug-resistant TB, which doesn’t respond to any of the traditional treatments, can cost nearly half a million dollars and even this cost doesn’t guarantee that the patient will be cured of the disease.
What Has Been Done?
TB causes more deaths globally than any other infectious diseases. It is airborne and released when an infected patient coughs or sneezes, and can easily be caught by anyone who is in close proximity to the infected individual.
The current immigration polices both in the U.S. and in areas like London do not allow for the screening and/or treatment of potentially infected individuals. Instead, large numbers of these individuals are living together, often in small or substandard housing which creates the perfect transmission conditions for TB and other similar diseases.
The Centers for Disease Control have guidelines in place requiring medical examinations for any refugees or immigrants coming into the United States, whether they are here on a temporary visa or permanently. Unfortunately, they can only perform these exams if the individuals are entering the country legally. Individuals who carry TB and other similar diseases but are not able to be examined are carrying a disease that was nearly eradicated in many countries into fresh breeding grounds.
During the last 20 years, overuse of antibiotics has helped to create drug-resistant strains of the bacterium that have turned tuberculosis from a Victorian-era disease that was often romanticized into something that needs to be feared and respected once again.
Concentration in Cases
While the overall number of tuberculosis cases in the U.S. is dropping, a number of population subsets are increasingly affected by the disease.
A number of factors put individuals at risk for contracting TB, including weakened immune systems or medical professionals pass on the infection after treating infected patients. A 2014 report by the CDC revealed some worrisome trends, including the fact that more than 50 percent of TB cases are concentrated in four states: Florida, New York, Texas and Florida.
What do those four states have in common? They are also the main entry points for immigrants, both legal and illegal, who are entering the United States. As of 2013, more than 64 percent of TB cases were diagnosed in foreign-born individuals who had come to the United States.
Since a standard case of TB often costs around $17,000 to treat, many people who don’t have access to health care or insurance often go untreated, spreading the disease to anyone that they may come into contact with. Drug-resistant TB can cost even more, with a full treatment reaching $134,000. Extreme drug-resistant TB, which doesn’t respond to any of the traditional treatments, can cost nearly half a million dollars and even this cost doesn’t guarantee that the patient will be cured of the disease.
What Has Been Done?
TB causes more deaths globally than any other infectious diseases. It is airborne and released when an infected patient coughs or sneezes, and can easily be caught by anyone who is in close proximity to the infected individual.
The current immigration polices both in the U.S. and in areas like London do not allow for the screening and/or treatment of potentially infected individuals. Instead, large numbers of these individuals are living together, often in small or substandard housing which creates the perfect transmission conditions for TB and other similar diseases.
The Centers for Disease Control have guidelines in place requiring medical examinations for any refugees or immigrants coming into the United States, whether they are here on a temporary visa or permanently. Unfortunately, they can only perform these exams if the individuals are entering the country legally. Individuals who carry TB and other similar diseases but are not able to be examined are carrying a disease that was nearly eradicated in many countries into fresh breeding grounds.
What Precautions Need to be Taken?
While there is a great call right now for countries to open their borders in the wake of the events in Syria that left many as refugees, the borders should be opened intelligently.
- Housing needs to be improved for refugees or immigrants so that large numbers of people are not crammed into small spaces.
- Individuals need to submit to a medical exam before being allowed to enter a country. A basic TB test usually takes less than 24 hours if the patient isn’t symptomatic.
- Medical establishments need to be more approachable — if an individual is presenting symptoms of TB, they should be able to approach a medical establishment for treatment, if for no other reason than to prevent the disease from spreading farther.
- The public as a whole, including refugees and immigrants, needs to be educated on the symptoms and effects of the disease. Someone might go about their day just thinking they have a bad cough while transmitting TB to everyone they meet.
Saturday 20 February 2016
Bingeing on health foods won’t boost your immune system
This comes from an article published in The Guardian, by Dara Mohammadi.
Here is an extract: "The immune system can be broadly split into two parts, the innate and the acquired response. On detection of infection, it’s the innate response that acts first. Though fast, it lacks in finesse, and deals with an invading pathogen in much the same way that the Ghostbusters might try to remove a ghost from a haunted hotel. It gunges the halls and doorways to try to flush it out (that’s why you fill up with phlegm and snot), it yanks up the thermostat to try to boil it (why you run a fever), and it shuts down the building until the problem is solved (it makes you depressed and lethargic so you don’t go out and pick up another infection while your immune system is at work)."
Friday 19 February 2016
On pathogenic bacteria
See:
Thursday 18 February 2016
Cleanroom Cleaning and Disinfection: Eight Steps for Success
Cleanrooms
in healthcare and pharmaceutical facilities must be kept in a state of
microbiological control. This is achieved in a number of ways, including the
physical operation of Heating, Ventilation, and Air Conditioning (HVAC)
systems, control of materials, properly gowned and trained personnel, and
through the use of defined cleaning techniques, together with the application
of detergents and disinfectants.
The
object of cleaning and disinfection is to achieve appropriate microbiological
cleanliness levels for the class of cleanroom for an appropriate period of
time. Thus the cleaning and disinfection of cleanrooms is an important part of
contamination control.
In
an article for Controlled Environments magazine, Tim Sandle examines eight key
steps to be followed, in relation to cleaning and disinfection, in helping to
keep cleanrooms “clean.”
Posted by Dr. Tim Sandle
Wednesday 17 February 2016
Bacterial Jiggle: Curious Motions of Syphilis and Lyme Disease (video)
The bacteria that cause syphilis and Lyme Disease have something extraordinary in common: they manage to propel themselves through their environment in spite of the fact their tails are located inside their bodies.
Jennifer Frazer has written an interesting article on the curious motions of specific bacteria for Scientific American.
The bacteria that cause syphilis and Lyme Disease have something extraordinary in common: they manage to propel themselves through their environment in spite of the fact their tails are located inside their bodies.
Jennifer Frazer has written an interesting article on the curious motions of specific bacteria for Scientific American.
The bacteria that cause syphilis and Lyme Disease have something extraordinary in common: they manage to propel themselves through their environment in spite of the fact their tails are located inside their bodies.
For bacteria, they're also unusually shaped and active. In this movie, you can see the bacteria that cause Lyme Disease moving like living, squirming cavatappi.
Subscribe to:
Posts (Atom)